PharmaNess is one of the most important Italian non-profit Research Centres focusing on pharmacology and biotechnology.
PharmaNess holds a leader position in the Biomedicine District of Sardinia and it works in close collaboration with prestigious Universities, research institutes and private organizations located in Italy and in other countries.
PharmaNess was founded in 1996 as a spin-off of the University of Cagliari and at present 75% of its shares are owned by private equity, while the University of Cagliari and the National Research Council (CNR) own the remaining 25%.
PharmaNess is a research and development company, that “under the same roof” designs, synthesizes and formulates pharmaceutical products and tests them in pre-clinical pharmacology to identify new therapeutic strategies for treating pathologies with a high social impact.
Cannabinoid technology products developed by PharmaNess have been recently licensed to CeneRx (www.cenerx.com) and are promisingly moving ahead toward the clinical pipeline. Other international patents are held by PharmaNess in the field of analgesia and drug delivery.

In addition, PharmaNess provides a wide range of services to give custom-made solutions to pharmaceutical and biotechnological companies, Universities and research institutes which intend to add values to their results.